Takeshi Kouga
Overview
Explore the profile of Takeshi Kouga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurokawa Y, Osaka H, Kouga T, Jimbo E, Muramatsu K, Nakamura S, et al.
Hum Gene Ther
. 2020 Dec;
32(11-12):589-598.
PMID: 33256498
Niemann-Pick disease type C1 (NPC1) is a fatal congenital neurodegenerative disorder caused by mutations in the gene, which is involved in cholesterol transport in lysosomes. Broad clinical manifestations of NPC1...
2.
Miyauchi A, Kouga T, Jimbo E, Matsuhashi T, Abe T, Yamagata T, et al.
Mitochondrion
. 2019 Jul;
49:111-120.
PMID: 31356884
Mitochondrial disease is a genetic disorder in which individuals suffer from energy insufficiency. The various clinical phenotypes of mitochondrial disease include Leigh syndrome (LS), myopathy encephalopathy lactic acidosis and stroke-like...
3.
Kouga T, Koizume S, Aoki S, Jimbo E, Yamagata T, Inoue K, et al.
Mol Genet Metab Rep
. 2019 May;
20:100474.
PMID: 31110947
Background: Pelizaeus-Merzbacher disease (PMD) is caused by point mutations or copy number changes in the proteolipid protein 1 gene (). is exclusively localized in the myelin sheath of oligodendrocytes. Amino...
4.
5.
Kouga T, Takagi M, Miyauchi A, Shimbo H, Iai M, Yamashita S, et al.
Brain Dev
. 2017 Sep;
40(2):145-149.
PMID: 28916229
Background: Leigh syndrome is a mitochondrial disease caused by respiratory chain deficiency, and there are no proven effective therapies. EPI-743 is a potent cellular oxidative stress protectant and results of...
6.
Nakashima M, Kouga T, Lourenco C, Shiina M, Goto T, Tsurusaki Y, et al.
Epilepsia
. 2015 Nov;
57(1):e18-23.
PMID: 26611353
Dynamin 1 (DNM1) is a large guanosine triphosphatase involved in clathrin-mediated endocytosis. In recent studies, de novo mutations in DNM1 have been identified in five individuals with epileptic encephalopathy. In...
7.
Kouga T, Tanoue K, Matsui K
J Craniofac Surg
. 2014 May;
25(3):762-5.
PMID: 24820706
Syndromic craniosynostosis is associated with a high rate of respiratory difficulty, due mainly to midfacial hypoplasia. Nasopharyngeal airway establishment has been reported as the first-line approach to airway obstruction and...
8.
Kouga T, Shimbo H, Iai M, Yamashita S, Ishii A, Ihara Y, et al.
Brain Dev
. 2014 May;
37(2):243-9.
PMID: 24819914
Objective: The objective of this study was to investigate stiripentol (STP) administration in cases of Dravet syndrome (DS) by comparing CYP2C19 allelic polymorphisms with the clinical effects of STP, including...
9.
Kouga T, Iai M, Yamashita S, Aida N, Takanashi J, Osaka H
Neuropediatrics
. 2012 Dec;
44(4):199-202.
PMID: 23254571
In this study, we report the case of an 8-year-old girl who had three episodes of reversible splenial lesion of the corpus callosum (SCC) in 2 years. Vomiting, hypoglycemia, and...